TY - JOUR
T1 - Layer-by-layer deposited nano- and micro-assemblies for insulin delivery
T2 - A review
AU - Yoshida, Kentaro
AU - Hasebe, Yasushi
AU - Takahashi, Shigehiro
AU - Sato, Katsuhiko
AU - Anzai, Jun Ichi
N1 - Funding Information:
This work was supported in part by JSPS KAKENHI Grant Number 24390006 .
PY - 2014
Y1 - 2014
N2 - We present an overview of the recent progress in the development of layer-by-layer (LbL) assembled thin films and microcapsules for insulin delivery. The LbL deposition of insulin-containing thin films on the surfaces of flat substrates or microparticles has been investigated for orally administered insulin formulations. The amount of insulin in the LbL films can be precisely controlled by altering the number of layers in the films. As-prepared LbL films and microcapsules can be loaded with insulin by exposing the films and microcapsules to an insulin solution. The insulin can be released by pH-induced decomposition or permeability changes in the LbL films and microcapsules. Closed-loop insulin delivery systems that can release insulin in response to changes in glucose concentration have also been constructed with LbL films and microcapsules. Glucose-sensitive materials, such as glucose oxidase, concanavalin A, and phenylboronic acid, have been incorporated into insulin-containing LbL assemblies. In addition, LbL film-coated pancreatic islet cells have recently been developed as a bio-artificial pancreas, in which the islet cells are isolated from the recipient's immune system by the LbL coatings. Thus, LbL films and microcapsules could make a significant contribution to the further development of patient-friendly insulin delivery systems.
AB - We present an overview of the recent progress in the development of layer-by-layer (LbL) assembled thin films and microcapsules for insulin delivery. The LbL deposition of insulin-containing thin films on the surfaces of flat substrates or microparticles has been investigated for orally administered insulin formulations. The amount of insulin in the LbL films can be precisely controlled by altering the number of layers in the films. As-prepared LbL films and microcapsules can be loaded with insulin by exposing the films and microcapsules to an insulin solution. The insulin can be released by pH-induced decomposition or permeability changes in the LbL films and microcapsules. Closed-loop insulin delivery systems that can release insulin in response to changes in glucose concentration have also been constructed with LbL films and microcapsules. Glucose-sensitive materials, such as glucose oxidase, concanavalin A, and phenylboronic acid, have been incorporated into insulin-containing LbL assemblies. In addition, LbL film-coated pancreatic islet cells have recently been developed as a bio-artificial pancreas, in which the islet cells are isolated from the recipient's immune system by the LbL coatings. Thus, LbL films and microcapsules could make a significant contribution to the further development of patient-friendly insulin delivery systems.
KW - Artificial pancreas
KW - Drug delivery
KW - Insulin delivery
KW - Layer-by-layer film
KW - Microcapsule
UR - http://www.scopus.com/inward/record.url?scp=84889099146&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84889099146&partnerID=8YFLogxK
U2 - 10.1016/j.msec.2013.09.045
DO - 10.1016/j.msec.2013.09.045
M3 - Review article
C2 - 24268273
AN - SCOPUS:84889099146
SN - 0928-4931
VL - 34
SP - 384
EP - 392
JO - Materials Science and Engineering C
JF - Materials Science and Engineering C
IS - 1
ER -